Market Overview:
全球艾滋病毒药物市场在2020年的价值达到264亿美元。展望未来，IMARC集团预计到2026年，该市场的价值将达到329亿美元。请记住，Covid-19的不确定性，我们一直在跟踪欧宝电竞首页我们的不确定性。并评估大流行的直接和间接影响。这些见解作为主要市场贡献者包含在报告中。
Human Immunodeficiency Virus (HIV) is a chronic and life-threatening disease which can be transferred from one person to another through blood-to-blood and sexual contact. It is a virus which attacks immune cells known as CD-4 cells, making body susceptible to infections and other diseases. Over the years, the rising prevalence of HIV disease worldwide has positively influenced the demand for HIV drugs. HIV drugs help in preventing the multiplication of HIV, thereby reducing the risk of its transmission.
催化全球艾滋病毒药物市场增长的主要因素之一是艾滋病毒的患病率及其诊断。除此之外，市场还受到政府倡议数量的增加，该计划在人们之间就原因，症状和治疗方面传播了认识。此外，引入具有成本效益且与品牌药物相同的仿制药引入，它是有助于艾滋病毒药物需求的另一个因素。
Key Market Segmentation:
欧宝电竞首页IMARC集团对全球艾滋病毒药物市场的每个子细分市场的关键趋势进行了分析，以及2021 - 2026年全球，区域和国家水平的预测。我们的报告根据班级和分销渠道对市场进行了分类。
按课堂分手：
- 核苷逆转录酶抑制剂
- Multi-Class Combination Products
- 蛋白酶抑制剂
- HIV整合酶链转移抑制剂
- 非核苷逆转录酶抑制剂
- 进入抑制剂 - CCR5共受体拮抗剂
- 融合抑制剂和其他
Based on class, the market has been segmented into multi-class combination products, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, entry inhibitors - CCR5 co-receptor antagonist and HIV integrase strand transfer inhibitors.
Breakup by Distribution Channel:
- 医院药房
- 零售Pharmacies
- 在线药房
- 其他
On the basis of distribution channel, the market is segregated as hospital pharmacies, retail pharmacies, online pharmacies and others. Hospital pharmacies currently account for the largest share.
区域见解：
- 北美
- Europe
- 亚太地区
- Middle East and Africa
- Latin America
Region-wise, the market has been segmented into Europe, Asia Pacific, North America, Middle East and Africa, and Latin America. Amongst these, North America is the leading market accounting for the majority of the global market.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players being
- Bristol-Myers Squibb
- Gilead Sciences
- 葛兰素史克
- 约翰逊和约翰逊
- Merck.
该报告提供了对涵盖其所有基本方面的全球艾滋病毒药物市场的深入了解。This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the HIV drugs market in any manner.
报告覆盖范围：
| Report Features |
细节 |
| Base Year of the Analysis |
2020 |
| 历史时期 |
2015-2020 |
| Forecast Period |
2021-2026 |
| Units |
US$ Billion |
| Segment Coverage |
班级，分销渠道，区域 |
| Region Covered |
亚太地区, Europe, North America, Latin America, Middle East and Africa |
| Companies Covered |
Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck |
| Customization Scope |
10%免费定制 |
| 报告价格和购买选项 |
单用户许可证：US $ 2299
Five User License: US$ 3399
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12周 |
| Delivery Format |
PDF和通过电子邮件excel（我们还可以根据特殊要求提供PPT/Word格式的报告的可编辑版本） |
1个序言
2Scope and Methodology
2.1研究的目标
2。2Stakeholders
2。3Data Sources
2。3。1Primary Sources
2.3.2次要来源
2.4市场估计
2.4.1自下而上的方法
2。4.2 Top-Down Approach
2。5 Forecasting Methodology
3Executive Summary
4简介
4.1 Overview
4.2关键行业趋势
5 Global HIV Drugs Market
5.1市场概述
5.2市场表现
5.3 COVID-19的影响
5.4价格分析
5.5 Market Breakup by Drug Class
5.6 Market Breakup by Distribution Channel
5.7按地区破裂
5.8市场预测
5.9 SWOT分析
5.9.1概述
5.9.2优势
5.9.3弱点
5.9.4机会
5.9.5威胁
5.10价值链分析
5.10.1 Overview
5.10.2 Research and Development
5.10.3原材料采购
5.10.4制造
5.10.5 Marketing
5.10.6分布
5.10.7 End-Use
5.11 Porters Five Forces Analysis
5.11.1概述
5.11.2 Bargaining Power of Buyers
5.11.3供应商的议价能力
5.11.4竞争程度
5.11.5新进入者的威胁
5.11.6 Threat of Substitutes
6毒品分类的市场分手
6.1 Nucleoside Reverse Transcriptase Inhibitors
6.1.1市场趋势
6.1.2市场预测
6.2 Multi-Class Combination Products
6.2.1 Market Trends
6.2.2 Market Forecast
6.3蛋白酶抑制剂
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 HIV Integrase Strand Transfer Inhibitors
6.4.1市场趋势
6.4.2市场预测
6.5非核苷逆转录酶抑制剂
6.5.1 Market Trends
6.5.2市场预测
6.6进入抑制剂 - CCR5共受体拮抗剂
6.6.1 Market Trends
6.6.2市场预测
6.7融合抑制剂和其他人
6.7.1市场趋势
6.7.2市场预测
7 Market Breakup by Distribution Channel
7.1医院药房
7.1.1市场趋势
7.1.2市场预测
7.2零售药店
7.2.1市场趋势
7.2.2市场预测
7.3在线药房
7.3.1市场趋势
7.3.2 Market Forecast
7.4 Others
7.4.1市场趋势
7.4.2 Market Forecast
8 Market Breakup by Region
8.1北美
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1市场趋势
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1市场趋势
8.3.2 Market Forecast
8.4中东和非洲
8.4.1 Market Trends
8.4.2 Market Forecast
8.5拉丁美洲
8.5.1市场趋势
8.5.2市场预测
9 HIV Drugs Manufacturing Process
9.1 Product Overview
9.2原材料要求
9.3制造过程
9.4关键成功和风险因素
10 Competitive Landscape
10.1 Market Structure
10.2主要参与者的市场破裂
10.3 Profiles of Key Players
10.3.1 Boehringer Ingelheim International GmbH
10.3.2 Merck＆Co.，Inc。
10.3.3 VIIV医疗保健
10.3.4 AbbVie
10.3.5 F. Hoffmann-La Roche Ltd.
10.3.6 Teva Pharmaceutical OB欧宝体育Industries Ltd.
10.3.7布里斯托尔美犬
10.3.8 Gilead Sciences, Inc.
10.3.9 Johnson & Johnson
10.3.10 Cipla Limited
10.3.11 Daiichi Sankyo
10.3.12 Emcure
10.3.13 Hetero Drugs
10.3.14迈兰
的列表Figures
Figure 1: Global: HIV Drugs Market: Major Drivers and Challenges
Figure 2: Global: HIV Drugs Market: Sales Value (in Billion US$), 2015-2020
图3：全球：艾滋病毒药物市场：毒品分类分手（百分比），2020年
Figure 4: Global: HIV Drugs Market: Breakup by Distribution Channel (in %), 2020
图5：全球：艾滋病毒药物市场：按地区分手（百分比），2020年
图6：全球：艾滋病毒药物市场预测：销售价值（十亿美元），2021-2026
Figure 7: Global: HIV Drugs Industry: SWOT Analysis
Figure 8: Global: HIV Drugs Industry: Value Chain Analysis
Figure 9: Global: HIV Drugs Industry: Porter’s Five Forces Analysis
图10：全球：HIV药物（核苷逆转录酶抑制剂）市场：销售价值（百万美元），2015年和2020年
图11：全球：HIV药物（核苷逆转录酶抑制剂）市场预测：销售价值（百万美元），2021-2026
Figure 12: Global: HIV Drugs (Multi-Class Combination Products) Market: Sales Value (in Million US$), 2015 & 2020
图13：全球：艾滋病毒药物（多级组合产品）市场预测：销售价值（百万美元），2021-2026
Figure 14: Global: HIV Drugs (Protease Inhibitors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: HIV Drugs (Protease Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
图16：全球：艾滋病毒药物（HIV整合酶链转移抑制剂）市场：销售价值（百万美元），2015年和2020年
Figure 17: Global: HIV Drugs (HIV Integrase Strand Transfer Inhibitors) Market Forecast: Sales Value (in Million US$), 2021-2026
图18：全球：艾滋病毒药物（非核苷逆转录酶抑制剂）市场：销售价值（百万美元），2015年和2020年
图19：全球：艾滋病毒药物（非核苷逆转录酶抑制剂）市场预测：销售价值（百万美元以百万美元），2021- 2026
Figure 20: Global: HIV Drugs (Entry Inhibitors — CCR5 Co-Receptor Antagonist) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: HIV Drugs (Entry Inhibitors — CCR5 Co-Receptor Antagonist) Market Forecast: Sales Value (in Million US$), 2021-2026
图22：全球：艾滋病毒药物（融合抑制剂和其他市场）市场：销售价值（百万美元），2015年和2020年
图23：全球：艾滋病毒药物（融合抑制剂等）市场预测：销售价值（百万美元），2021-2026
图24：全球：艾滋病毒药物市场：通过医院药房的销售（百万美元），2015年和2020年
Figure 25: Global: HIV Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2021-2026
图26：全球：艾滋病毒药物市场：通过零售药店的销售（百万美元），2015年和2020年
Figure 27: Global: HIV Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2021-2026
图28：全球：艾滋病毒药物市场：通过在线药房的销售（百万美元），2015年和2020年
Figure 29: Global: HIV Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2021-2026
Figure 30: Global: HIV Drugs Market: Sales through Other Distribution Channels (in Million US$), 2015 & 2020
Figure 31: Global: HIV Drugs Market Forecast: Sales through Other Distribution Channels (in Million US$), 2021-2026
图32：北美：艾滋病毒药物市场：销售价值（百万美元），2015年和2020年
Figure 33: North America: HIV Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
图34:欧洲:艾滋病药物市场销售价值(in Million US$), 2015 & 2020
图35：欧洲：艾滋病毒药物市场预测：销售价值（百万美元），2021-2026
Figure 36: Asia Pacific: HIV Drugs Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Asia Pacific: HIV Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Middle East and Africa: HIV Drugs Market: Sales Value (in Million US$), 2015 & 2020
图39：中东和非洲：艾滋病毒药物市场预测：销售价值（百万美元），2021-2026
图40：拉丁美洲：艾滋病毒药物市场：销售价值（百万美元），2015年和2020年
Figure 41: Latin America: HIV Drugs Market Forecast: Sales Value (in Million US$), 2021-2026
图42：艾滋病毒药物制造：详细过程流动
Figure 43: Global: HIV Drugs Market: Breakup by Key Players (in %)
表列表
Table 1: Global: HIV Drugs Market: Key Industry Highlights, 2020 and 2026
表2：全球：艾滋病毒药物市场预测：毒品类别分手（百万美元），2021-2026
Table 3: Global: HIV Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
表4：全球：艾滋病毒药物市场预测：按地区分手（百万美元），2021-2026
表5：HIV药物制造：原材料要求
Table 6: Global: HIV Drugs Market: Competitive Structure
Table 7: Global: HIV Drugs Market: Key Players